Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
General Introduction | Dirui Medical Technology Co., Ltd. (stock code: 300396), as a high-tech enterprise controlled by China Resources Industrial Fund, was founded in Changchun, China in 1992. It is one of the leading enterprises in the domestic in vitro diagnostic industry and a national technology innovation demonstration enterprise. The company focuses on the research and development, production, marketing, and service of high-quality medical laboratory products, wholeheartedly contributing wisdom and strength to safeguarding life and health. It now has 8 major product lines, including urine analysis, biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, molecular diagnostic analysis, and integrated laboratory, covering over 80% of the testing projects in the hospital laboratory, and can provide overall solutions for medical laboratories. We continuously invest 10% -15% of our annual sales revenue into the research and development of products and technologies. We have built an internationally renowned medical laboratory product research and development platform, with fully automated urine analysis systems, urine dry chemical analysis quality control materials, gynecological secretion analysis systems and other product technologies reaching industry-leading levels. After 30 years of deep cultivation in the industry, Dirui products have gained the trust of over 14000 medical institutions in China and users from over 120 countries and regions worldwide. The fully automatic urine analyzer has a market share of over 28% in the domestic tertiary market, and urine products rank first in market share in some European countries. Under the guidance of the "14th Five Year Plan" development strategy, the company has established two major research institutes in Changchun and Shenzhen, three major operation centers in Changchun, Beijing, and Wuhan, 26 provincial offices, and 7 international overseas subsidiaries, covering more than 120 countries and regions. All Dirui people will actively fulfill the corporate mission, always remember the corporate vision, and showcase the charm of China's intelligent manufacturing to the world. |
Headquarter | Changchun |
Establish Date | 12/26/1994 |
Listed Code | 300396.SZ |
Listed Date | 9/10/2014 |
Chairman | Song Qing. |
CEO | Wang Xuemin. |
Website | www.dirui.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial